Antimicrobial Susceptibility Testing Market by Product (Manual Testing, Automated AST, Consumable), Method (Disk Diffusion, Dilution), Application (Clinical Diagnosis, Epidemiology), End User (Diagnostic Laboratories, Hospital) – Global Forecast to 2027
The global antimicrobial susceptibility testing market is expected to grow at a CAGR of 6.1% from 2019 to 2027 to reach $5.09 billion by 2027. The growth in the overall antimicrobial susceptibility testing market is mainly attributed to high prevalence of infectious diseases, increased funding and government initiatives, emergence of multidrug resistance, and technological advancements towards development of rapid AST methods. In addition, emerging markets will further provide significant opportunities for the various stakeholders in this market. However, stringent government regulations for antimicrobial susceptibility testing products are likely to hinder the market growth.
The overall antimicrobial susceptibility testing market is mainly segmented by product (manual antimicrobial susceptibility testing products, automated antimicrobial susceptibility testing products, consumable), method (disk diffusion, rapid automated AST, dilution, and other methods), application (clinical diagnosis, drug discovery & development, and other applications), end user (diagnostic laboratories, hospitals, pharma biotech industry, and research & academic institutes), and geography.
On the basis of product, the manual antimicrobial susceptibility testing products segment accounted for the largest share of the overall market in 2019. The large share of this segment is mainly attributed to the factors such as rising prevalence of infectious diseases which leads to an increased demand for susceptibility testing products. The greater adoption of these products is also due to the benefits offered such as low cost and the ease of use of these products.
On the basis of method, the disk diffusion segment accounted for the largest share of the overall antimicrobial susceptibility testing market in 2019. Simplicity of the test, low cost, and flexibility in selection of disks are the key factors contributing to the largest share of this segment.
Based on the application area, the clinical diagnostics segment accounted for the largest share of this market in 2019, owing to the factors such as growing awareness about the use of antimicrobial susceptibility testing methods for diagnostic applications, rising burden of antimicrobial resistance, and positive government intervention regarding early disease screening.
On the basis of end user, diagnostic laboratories and hospitals held the largest share of the overall antimicrobial susceptibility testing market in 2019. Factors contributing to its largest share are the availability of well-equipped facilities and trained/skilled technicians, rise in hospital-acquired infections, and various initiatives taken by key players to offer AST products through diagnostic laboratories & hospitals.
An in-depth analysis of the geographic scenario of the antimicrobial susceptibility testing market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America commanded the largest share of the global antimicrobial susceptibility testing market in 2019, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. During the forecast period, Asia-Pacific region offers higher growth potential in this market. The factors such as growing number of infectious diseases, increasing public health awareness & self-medication, and growing use of antibiotics without prescription resulting into antimicrobial resistance drives the growth of AST market in this region.
The key players operating in the global antimicrobial susceptibility testing market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China).
Scope of the Report:
Global Antimicrobial Susceptibility Testing Market, by Method
Other methods includes Etest & Genotypic Methods
Global Antimicrobial Susceptibility Testing Market, by Product
Manual Antimicrobial Susceptibility Testing Products
Susceptibility Testing Disks
Automated Laboratory Instruments
Global Antimicrobial Susceptibility Testing Market, by Application
Drug Discovery and Development
Other applications includes veterinary research, epidemiology & environmental monitoring.
Global Antimicrobial Susceptibility Testing Market, by End user
Diagnostic Laboratories and Hospitals
Pharmaceutical and Biotechnology Companies
Research and Academic Institutes
Global Antimicrobial Susceptibility Testing Market, by Geography
Rest of Europe (RoE)
Rest of APAC (RoAPAC)
Middle East & Africa
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook